Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in... see more

TSXV:BTI.H - Post Discussion

biOasis Technologies Ord Shs > Non-human primate testing
View:
Post by prophetoffactz on May 04, 2023 9:08am

Non-human primate testing

@JMaraganore
 
New CNS #RNAi data from
@alnylam
!

Unbelievable >80% APP silencing at top dose!

See translation from NHP to human… “Monkey see, Human do” for RNAi in CNS… JUST LIKE LIVER! Implications? We will see reproducible and modular approach for RNAi toward major Neuro degenerative Dz!
 
Comment by prophetoffactz on May 04, 2023 9:14am
This guy ran the largest RNAi company and is saying the RNAi gold rush for the CNS is on.
Comment by Boomskid on May 04, 2023 10:05am
Can you explain to us, poof, how RNAi might compete with the transport of existing therapies like Herceptin (xB3-001), IL-1Ra (xB3-004), and other biologics across the BBB? You have an irresponsible habit of posting with no analysis or context. For years it's been left to me and others to clean up the messes you've created. Tell us the scope of possibilities with RNAi, how it might ...more  
biOasis Technologies Ord Shs